InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kevin Tang, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 32 open-market SEC Form 4 transactions: 32 purchases worth $57.2M and 0 sales worth $0, reported from Dec 5, 24 to Jul 21, 26. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 26 | BOLDBoundless Bio, Inc. | BUY | 3.0K | $2.44 | $7K |
| Jul 20, 26 | BOLDBoundless Bio, Inc. | BUY | 1.6K | $2.44 | $4K |
| Jul 17, 26 | BOLDBoundless Bio, Inc. | BUY | 265 | $2.44 | $647 |
| Jul 15, 26 | FULCFulcrum Therapeutics, Inc. | BUY | 107.4K | $3.56 | $382K |
| Jul 14, 26 | FULCFulcrum Therapeutics, Inc. | BUY | 76.0K | $3.58 | $272K |
| Jul 13, 26 | FULCFulcrum Therapeutics, Inc. | BUY | 13.0K | $3.54 | $46K |
| Jul 13, 26 | BOLDBoundless Bio, Inc. | BUY | 48.2K | $2.42 | $117K |
| Jul 10, 26 | BOLDBoundless Bio, Inc. | BUY | 43.4K | $2.43 | $105K |
| Jul 8, 26 | BOLDBoundless Bio, Inc. | BUY | 14.3K | $2.46 | $35K |
| Jul 7, 26 | BOLDBoundless Bio, Inc. | BUY | 15.8K | $2.48 | $39K |
| Jul 6, 26 | BOLDBoundless Bio, Inc. | BUY | 27.1K | $2.49 | $67K |
| Jul 2, 26 | BOLDBoundless Bio, Inc. | BUY | 9.8K | $2.49 | $24K |
| Jul 1, 26 | BOLDBoundless Bio, Inc. | BUY | 71.6K | $2.49 | $178K |
| Jun 30, 26 | BOLDBoundless Bio, Inc. | BUY | 25.9K | $2.54 | $66K |
| Jun 29, 26 | BOLDBoundless Bio, Inc. | BUY | 64.0K | $2.48 | $158K |
| Jun 26, 26 | BOLDBoundless Bio, Inc. | BUY | 75.0K | $2.55 | $191K |
| Jun 25, 26 | BOLDBoundless Bio, Inc. | BUY | 145.9K | $2.56 | $362K |
| Jun 2, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 206.0K | $15.28 | $3.1M |
| Jun 1, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 343.5K | $15.34 | $5.2M |
| May 29, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 262.7K | $15.35 | $4.0M |
| Mar 3, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 184.2K | $14.22 | $2.6M |
| Mar 2, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 115.8K | $14.33 | $1.6M |
| Feb 27, 26 | AUPHAurinia Pharmaceuticals Inc. | BUY | 300.0K | $14.38 | $4.2M |
| Aug 5, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 200.0K | $11.68 | $2.3M |
| Aug 4, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 100.0K | $11.34 | $1.1M |
| Aug 1, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 1.00M | $10.12 | $10.1M |
| Mar 4, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 500.0K | $8.09 | $4.0M |
| Mar 3, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 352.0K | $8.02 | $2.8M |
| Feb 28, 25 | AUPHAurinia Pharmaceuticals Inc. | BUY | 399.3K | $7.85 | $3.1M |
| Dec 9, 24 | AUPHAurinia Pharmaceuticals Inc. | BUY | 500.0K | $9.09 | $4.5M |
| Dec 6, 24 | AUPHAurinia Pharmaceuticals Inc. | BUY | 400.0K | $9.01 | $3.6M |
| Dec 5, 24 | AUPHAurinia Pharmaceuticals Inc. | BUY | 300.0K | $8.91 | $2.7M |